CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

AIM: To evaluate the diagnosis value of serum human epididymis protein 4 (HE4), cancer antigen 125 (CA125), the Risk of Ovarian Malignancy Algorithm (ROMA), and Copenhagen Index (CPH-I) at early stages for differentiating borderline ovarian tumors from epithelial ovarian cancer. METHODS: We recruite...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiheng, Tao, Xiang, Ying, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815620/
https://www.ncbi.nlm.nih.gov/pubmed/31737130
http://dx.doi.org/10.1155/2019/6241743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815620/
https://www.ncbi.nlm.nih.gov/pubmed/31737130
http://dx.doi.org/10.1155/2019/6241743

Ejemplares similares